Search

Displaying 241 - 252 items out of 293 results
Press release
CheckMate 77T: Nivolumab Maintains Quality of Life and Reduces Symptom Deterioration in Resectable NSCLC
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
ELCC 2018 Press Release: Further Evidence that Immunotherapy Provides a Long-term Survival Benefit for Lung Cancer Patients
… (European Lung Cancer Congress)  in Geneva, Switzerland. Researchers presented the three-year survival results of the … Novartis, Ono Pharmaceutical, Roche. Speakers Bureau: BI, Research Funding: AZ. C. Lewanski: Consultant: MSD, Roche, AZ. …
Press release
Phase II Study of Taletrectinib Shows Durable Overall Response and Favorable Safety in Patients with ROS1+ Non-Small Cell Lung Cancer 
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
NELSON Study Shows CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26 Percent in Men
… and other thoracic malignancies, attracting over 7,000 researchers, physicians and specialists from more than 100 … will cover a wide range of disciplines and unveil research studies and clinical trial results. For more …
Press release
IASLC Award Recognizes Importance of Cancer Care Teamwork at Annual World Conference
… other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
COMPEL Study Shows Continuing Osimertinib Treatment Through Progression with the Addition of Chemotherapy Improves Progression-Free Survival in EGFR-Mutated NSCLC
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
Ivonescimab Outperforms Pembrolizumab in Phase 3 Study for First-Line Treatment of PD-L1-Positive Advanced NSCLC In HARMONi-2 Study 
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
IASLC Awards Joseph W. Cullen Prevention/Early Detection Award to William Evans at the World Conference on Lung Cancer
… other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
Crizotinib Fails to Improve Disease-Free Survival in Resected Early-Stage ALK+ NSCLC
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians, and specialists from more than 100 … covers a wide range of disciplines and unveils several research studies and clinical trial results. For more …
Press release
Tarlatamab with Anti-PD-L1 as First-Line Maintenance After Chemo-Immunotherapy for ES-SCLC Demonstrates Acceptable Safety Profile and Unprecedented Overall Survival
Press release
Study Discloses Clinical-Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping
… other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …
Press release
NADIM ADJUVANT Trial Suggests Benefit of Adjuvant Chemo-Immunotherapy in Resected Stage IB–IIIA NSCLC
… and other thoracic malignancies, attracting nearly 7,000 researchers, physicians, and specialists from more than 100 … will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more …